TRPC6-IN-1 is primarily utilized in research settings to investigate the role of TRPC6 channels in various physiological and pathological processes. It is often employed in studies focused on understanding cardiovascular diseases, as TRPC6 channels are implicated in conditions such as cardiac hypertrophy and hypertension. Additionally, this compound is used to explore its potential therapeutic effects in kidney diseases, particularly in podocyte injury and glomerular disorders. Researchers also leverage TRPC6-IN-1 to study its impact on neuronal functions, including synaptic plasticity and neurodegenerative diseases. Its application extends to pharmacological studies aimed at developing targeted therapies for diseases associated with TRPC6 channel dysfunction.